Literature DB >> 23274471

Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer.

Harald von Boehmer1, Carolin Daniel.   

Abstract

Forkhead box P3 (FOXP3)-expressing regulatory T (T(Reg)) cells have a pivotal role in the regulation of immune responses and in the maintenance of immunological self-tolerance. These cells have emerged as attractive targets for strategies that allow the steering of immune responses in desired directions - arming the immune system to destroy infected cells and cancer cells or downregulating it to limit tissue destruction in autoimmunity. Efforts to understand the generation, activation and function of T(Reg) cells should permit the development of therapeutics for reprogramming the immune system. In this Review, we discuss insights into the generation of T(Reg) cells, their involvement in disease and the molecular basis of the dominant tolerance exerted by FOXP3(+) T(Reg) cells that could permit their safe and specific manipulation in humans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23274471     DOI: 10.1038/nrd3683

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  186 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

Review 2.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

3.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.

Authors:  K H Lee; K W Wucherpfennig; D C Wiley
Journal:  Nat Immunol       Date:  2001-06       Impact factor: 25.606

5.  CD4+Foxp3+ regulatory T-cell impairment by paclitaxel is independent of toll-like receptor 4.

Authors:  Y Zhu; N Liu; S D Xiong; Y J Zheng; Y W Chu
Journal:  Scand J Immunol       Date:  2011-04       Impact factor: 3.487

Review 6.  STAT3: a target to enhance antitumor immune response.

Authors:  Heehyoung Lee; Sumanta Kumar Pal; Karen Reckamp; Robert A Figlin; Hua Yu
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

7.  Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

Authors:  Kirsti Näntö-Salonen; Antti Kupila; Satu Simell; Heli Siljander; Tiina Salonsaari; Anne Hekkala; Sari Korhonen; Risto Erkkola; Jukka I Sipilä; Lotta Haavisto; Marja Siltala; Juhani Tuominen; Jari Hakalax; Heikki Hyöty; Jorma Ilonen; Riitta Veijola; Tuula Simell; Mikael Knip; Olli Simell
Journal:  Lancet       Date:  2008-09-22       Impact factor: 79.321

8.  Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

Authors:  Onur Boyman; Marek Kovar; Mark P Rubinstein; Charles D Surh; Jonathan Sprent
Journal:  Science       Date:  2006-02-16       Impact factor: 47.728

9.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice.

Authors:  D Daniel; R G Gill; N Schloot; D Wegmann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

10.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

View more
  78 in total

1.  Cancer immunotherapy: A vaccine from plant virus proteins.

Authors:  Pier Paolo Peruzzi; E Antonio Chiocca
Journal:  Nat Nanotechnol       Date:  2015-12-21       Impact factor: 39.213

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

3.  Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.

Authors:  Maura Rossetti; Roberto Spreafico; Suzan Saidin; Camillus Chua; Maryam Moshref; Jing Yao Leong; York Kiat Tan; Julian Thumboo; Jorg van Loosdregt; Salvatore Albani
Journal:  J Immunol       Date:  2014-12-01       Impact factor: 5.422

4.  MiRNome and transcriptome aided pathway analysis in human regulatory T cells.

Authors:  M H Albert; J Mannert; K K Fleischmann; M Schiemann; P Pagel; I Schmid; T Magg
Journal:  Genes Immun       Date:  2014-05-22       Impact factor: 2.676

5.  Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis.

Authors:  Bruce Kirkham; Khaldoun Chaabo; Christopher Hall; Toby Garrood; Timothy Mant; Elizabeth Allen; Alexandra Vincent; Joana C Vasconcelos; Andrew T Prevost; Gabriel S Panayi; Valerie M Corrigall
Journal:  Rheumatology (Oxford)       Date:  2016-08-07       Impact factor: 7.580

Review 6.  Harnessing FOXP3+ regulatory T cells for transplantation tolerance.

Authors:  Herman Waldmann; Robert Hilbrands; Duncan Howie; Stephen Cobbold
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

7.  Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.

Authors:  L Cavone; B Peruzzi; R Caporale; A Chiarugi
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

8.  Foxp3-dependent transformation of human primary CD4+ T lymphocytes by the retroviral protein tax.

Authors:  Li Chen; Dan Liu; Yang Zhang; Huan Zhang; Hua Cheng
Journal:  Biochem Biophys Res Commun       Date:  2015-09-14       Impact factor: 3.575

9.  Small Heterodimer Partner Regulates Dichotomous T Cell Expansion by Macrophages.

Authors:  Sayyed Hamed Shahoei; Young-Chae Kim; Samuel J Cler; Liqian Ma; Sayeepriyadarshini Anakk; Jongsook K Kemper; Erik R Nelson
Journal:  Endocrinology       Date:  2019-07-01       Impact factor: 4.736

Review 10.  Immune therapy for human papillomaviruses-related cancers.

Authors:  Ricardo Rosales; Carlos Rosales
Journal:  World J Clin Oncol       Date:  2014-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.